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LETTER TO EDITOR LANCET NEUROLOGY 
 
Assessing outcome after TBI:  Throwing the baby out with the bathwater? 
 
In their wide ranging and impressive review of TBI, Maas et al1 recommend the development 
and validation of multidimensional outcome constructs that quantify overall burden of 
disability from TBI. Their finding that there are already nearly 1000 instruments to consider is 
only one of many challenges that need to be overcome to achieve this aim.  
 
The assessment of outcome after TBI is complicated by influences of pre-injury as well as 
injury factors and the impact and response to the environment whether psychological, social 
or physical at various stages of recovery. Hence, many measures (eg cognition or quality of 
life), that might be within a ‘package’ aimed to improve sensitivity, are by their nature strongly 
influenced by socio-demographic and psychological factors and fundamentally lack specificity 
in detecting consequences of the initial brain injury. Practical considerations that include 
time, expense and completeness of follow up are vital in both clinical and research contexts, 
for any such tool to have utility. Hence a balance has to found between attempting to build a 
picture of the complex variable array of factors responsible for the state of an individual or 
using an overall index of survival and social handicap to characterise, classify and compare 
groups. The option of selecting from a range of recommended and validated tools2 to answer 
questions specific to the clinical or research focus in addition to a global overview should not 
be overlooked. New approaches being investigated include the development of formative 
measures composed of indicators that together determine the construct of outcome3.  
 
While the feasibility of achieving the aspiration of Mass et al is being explored, the findings 
from new tools need to be related to information gained from the ‘reflective’ global indices 
that have been used extensively over four decades4. We, therefore, welcome their 
recommendation to continue concurrent use of the GOS and GOSE. In a recent overview 
these scales showed significant differences in outcome in 29% of 112 different RCTs in which 
they were used as an end point5.  Moreover, the GOS has proved effective in follow up in 
middle and low income countries where, as the Lancet commission importantly emphasise, 
90% of deaths due to TBI occur. The merits of reliably detecting therapeutically relevant 
effects using refined vs simple indices with sufficient participants and state of the art 
statistical methods will be an important aspect of evaluation.  
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